{"name":"Targacept Inc.","slug":"targacept-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":275000,"revenueGrowth":116.5,"grossMargin":0,"rdSpend":13698000,"netIncome":9880000,"cash":166132000,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2014"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"date":"2026-03-23","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2026-03-13","type":"earnings","source":"SEC EDGAR","summary":"10-K filed with SEC: 10-K","headline":"Annual Report (10-K) Filed","sentiment":"neutral"},{"date":"2026-03-12","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2026-03-12","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2026-03-02","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2026-01-05","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: FORM 8-K","headline":"SEC 8-K: FORM 8-K","sentiment":"neutral"},{"date":"2025-11-07","type":"earnings","source":"SEC EDGAR","summary":"10-Q filed with SEC: 10-Q","headline":"Quarterly Report (10-Q) Filed","sentiment":"neutral"},{"date":"2025-11-07","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2025-09-10","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxNRGI3bXdFV3g5TENyRG4waXlCUUNZUkFwT1l3eWtpZ0J0WjBFRFlMY0VoZjhaazVDTFc0MWRocGJERjdhQkU2cXJFT3ljSU4xWGRoZDJLMi1qOEMtZFBpbEQtR3A4N3ZkdlE2TW9sM0oyOFZoUGJncnFRMzlBYjh6T0JCZ3RHVjJjYjhObHNCcVZCNUZiMVdTeUpVdldVM1lXV19SQXlCYS1Pakto?oc=5","date":"2025-08-28","type":"pipeline","source":"Pharmaceutical Online","summary":"AbbVie Enters Psychedelic Market With Bretisilocin Acquisition - Pharmaceutical Online","headline":"AbbVie Enters Psychedelic Market With Bretisilocin Acquisition","sentiment":"neutral"},{"date":"2025-08-22","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2025-08-11","type":"earnings","source":"SEC EDGAR","summary":"10-Q filed with SEC: 10-Q","headline":"Quarterly Report (10-Q) Filed","sentiment":"neutral"},{"date":"2025-08-11","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxNVG1kQ3VXV2U5VC10eFppMUkzZFVMMDNlQ21adHEyWExzUXMtY2doVU5qQXpBS3VtOXo5b3NMV2xhSEtTWUJiUHlyd1R6NFA0cFlaaE43ODN5SVVlUktVLTlSbGQ4U0RPLVpuUnVBU3hsd0VOMUhHcmttMVQ2UjJFa0xwYktJZHlXU1RFZ3RHWDA4M3RzUWtGaE5pRjlGMXpObXBnemFPb3I4Yi1SVzJVbw?oc=5","date":"2015-04-07","type":"deal","source":"BioPharma Dive","summary":"Targacept merger in jeopardy as Pfizer ends deal with buyer Catalyst - BioPharma Dive","headline":"Targacept merger in jeopardy as Pfizer ends deal with buyer Catalyst","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxQSVBZYlRHT1p4WkxLN3FXT0VJN19Ha1B3TExQT0xodlVfNXQ5TzRoeHFnQnZ3U2E1VDVXREZFb3ZILW00T19oaW0zRjdLQUU4cjhjd2p5RjJIVTZGd0hTdXYzMUY3RTIyNHdhWkNFQXh6U0NKQ2Rja3VCQVp2LVA2ZE5nTWhzSGVHR0dQMXpweUVEZw?oc=5","date":"2015-03-06","type":"pipeline","source":"BioSpace","summary":"Bay Area’s Catalyst Biosciences to Merge With Unlucky Targacept - BioSpace","headline":"Bay Area’s Catalyst Biosciences to Merge With Unlucky Targacept","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar","revenue":275000,"revenuePeriod":"2014-12-31","revenueHistory":[{"value":275000,"period":"2014-12-31"},{"value":127000,"period":"2014-12-31"},{"value":25000,"period":"2014-09-30"},{"value":36000,"period":"2014-06-30"},{"value":87000,"period":"2014-03-31"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":13698000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":9880000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":null,"cashHistory":[],"totalAssets":166132000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"ciks":null,"lastFiledAt":null},"yahoo":null}